The modeling effort drew on the National Health and Nutrition Survey (NHNS), an annual cross-sectional household examination survey that has tracked the diet, physical activity, lifestyle, anthropometrics, and laboratory profiles of approximately 8,000 to 11,000 Japanese residents aged one year and older since its restructuring in 2003. The team focused on glycemic data from adults aged 40 and above, defining diabetes as glycated hemoglobin A1c at or above 6.5 percent under the National Glycohemoglobin Standardization Program, or self-reported use of glucose-lowering medication. This definition corresponds to the official NHNS category of ‘strongly suspected diabetes’ rather than strictly diagnosed disease, a choice the authors argue is well suited to capturing the full population-level burden for surveillance and long-term projection. HbA1c values measured under earlier Japanese Diabetes Society guidelines were converted to NGSP equivalents using a standard linear formula, ensuring consistency across the entire 2003 to 2019 observation window.

What sets this study apart from earlier forecasting efforts is its treatment of three distinct temporal dimensions that conventional models typically ignore. Age effects capture how diabetes risk changes across the lifespan as glucose metabolism deteriorates with biological aging. Period effects reflect influences that operate across the entire population at a given calendar moment, such as expanded healthcare access, mass screening programs, and rising consultation rates. Cohort effects, the most subtle of the three, capture how people born in particular eras carry distinct lifetime risks shaped by early-life nutrition, wartime deprivation, and generational lifestyle patterns. Because age, period, and cohort are mathematically linearly dependent, the researchers relied on identifiable non-linear components, or curvatures, and fitted smoothing priors using first- and second-order random walks within a hierarchical Bayesian framework implemented in the R bamp package.

To test whether this added complexity actually buys predictive power, the team pitted the BAPC model against two conventional alternatives: one assuming constant prevalence frozen at 2019 levels, and another assuming monotonic change based on mean percentage shifts observed from 2003 to 2019. Splitting the data into a training period from 2003 to 2014 and a validation window from 2015 to 2019, they measured performance using root mean square error, or RMSE, which quantifies the average annual discrepancy between projected and observed case counts. The BAPC model achieved the lowest error for the total population and for both sexes, and its projections for 2022 through 2024 aligned more closely with the officially reported NHNS prevalence than either conventional model, providing a rare external validation of a long-range health forecast against real-world data.

The headline projections reveal a nation moving in two directions at once. Overall crude prevalence is projected to rise from 12.6 percent in 2020 to 14.0 percent in 2040, with total cases climbing from roughly 9.9 million to 10.4 million. Among men, the burden is heaviest in older age brackets: prevalence among those aged 70 to 74 is projected to reach 26.7 percent by 2040, and among those 75 to 79 it may hit 29.1 percent. Women show the opposite trajectory, with prevalence declining across nearly every age group, dropping most steeply among those aged 55 to 64. Notably, when the researchers age-standardized their estimates using the 2015 Japan Standard Population, the apparent rise in men largely flattened out, indicating that population aging, rather than worsening age-specific risk, is the dominant engine of the male increase.

A formal decomposition analysis confirmed this interpretation, attributing the growing prevalence in men to both rising age-specific prevalence and demographic aging, with the latter contributing more. The age-effect patterns estimated by the model showed an upward curvature in men that intensified until ages 65 to 69 and continued climbing thereafter, consistent with aging-related deterioration in glucose metabolism. The cohort effects told an equally revealing story. In men, prevalence rose gradually across successive generations, with modest upward curvature in older and intermediate birth cohorts. In women, the model detected downward curvature in intermediate and younger cohorts, suggesting that diabetes risk has been falling steeply among women born after the mid-twentieth century, a divergence the authors link partly to sex differences in body mass index trends and lifestyle factors.

The shadow of history looms over these cohort patterns. The intermediate birth cohort in the analysis, spanning those born between roughly 1940 and 1955, came of age amid the social upheaval of World War II and its aftermath, conditions that likely produced poor early-life nutrition. Prior research, including studies of the Dutch famine, has shown that nutritional deficiencies in early life can trigger elevated diabetes incidence decades later in adulthood. The researchers also point to more recent pressures: declining dietary fiber intake, reduced physical activity, and rising body mass index over the last decade, trends that have been notably more pronounced among Japanese men than women. Meanwhile, increasing healthcare access and consultation rates for diabetes may be raising detected and treated case counts, contributing to the estimated period effects even as serum glucose levels in the broader population have reportedly stabilized.

The projections come with important caveats. The 95 percent credible intervals widen dramatically as the forecast horizon extends, reaching as high as 40.8 percent for men by 2040, reflecting the genuine uncertainty inherent in predicting two decades into the future. The NHNS was suspended in 2020 and 2021 due to the COVID-19 pandemic, and the definition based on ‘strongly suspected diabetes’ may underestimate true prevalence by excluding the ‘diabetes cannot be ruled out’ category. The models also could not adjust for socioeconomic factors, lifestyle variables, or body mass index directly, and the 17-year observation window, constrained by the availability of standardized HbA1c data since 2003, is relatively short for long-horizon projection. Sensitivity analyses using stronger smoothing priors and down-sampled data for the expanded 2012 and 2016 survey cycles, however, produced results consistent with the main findings.

For policymakers, the message is unambiguous: Japan’s diabetes burden is set to grow, and it will fall disproportionately on men and the elderly. The authors urge a reform of public health policy encompassing strengthened primary care screening and early detection, targeted attention to the health needs of older adults and men, sustained monitoring of the disease burden, and preventive lifestyle interventions to head off complications. Previous Japanese modeling work has shown that rising diabetes prevalence partly offset reductions in coronary heart disease deaths achieved between 1980 and 2012 through medical advances and favorable risk factor changes, underscoring how easily gains in cardiovascular health can be eroded by a swelling diabetic population. As other nations in the Western Pacific grapple with similar demographic transitions, Japan’s experience, and the Bayesian tools used to forecast it, may offer a preview of the region’s metabolic future.

Subject of Research: Projection of diabetes mellitus prevalence and case numbers in Japan through 2040 using Bayesian age-period-cohort modeling of national survey data

Article Title: Projections of diabetes mellitus in Japan through 2040: a bayesian age-period-cohort analysis of the national health and nutrition survey population

Article References: Mondal, R., Ogata, S., Kiyoshige, E., Nakaoku, Y., Nakatsuka, K., Watanabe, T., Teramoto, K., Kadota, A., Miura, K., Kypridemos, C., Yoshikawa, Y., & Nishimura, K. (2026). Projections of diabetes mellitus in Japan through 2040: a bayesian age-period-cohort analysis of the national health and nutrition survey population. The Lancet Regional Health – Western Pacific, 74, Article 101988. https://doi.org/10.1016/j.lanwpc.2026.101988

Image Credits: AI Generated

DOI: 10.1016/j.lanwpc.2026.101988

Keywords: diabetes mellitus, Japan, Bayesian age-period-cohort model, prevalence projection, National Health and Nutrition Survey, population aging, cohort effects, sex differences, public health policy, HbA1c, epidemiology, The Lancet Regional Health Western Pacific

Leveraging the extensive data repository of the Global Burden of Disease Study (GBD) 2021, researchers undertook a granular evaluation of LOCC’s global, regional, and national epidemiology. The analysis encompassed crucial metrics, including incidence rates, mortality figures, and DALYs, providing an integrated measure of both premature death and disability attributable to LOCC. Notably, this research utilized the Bayesian Age-Period-Cohort (BAPC) model to generate forward-looking projections, a state-of-the-art statistical approach that accounts for temporal changes across different age groups, calendar periods, and birth cohorts.

The study’s findings reveal sobering trends and underscore the urgent need for targeted public health interventions. Globally, the number of new LOCC cases in 2021 surpassed 420,000, with South Asia bearing the highest burden. This region exhibited an age-standardized incidence rate of 9.8 per 100,000, far exceeding global averages. The mortality rate associated with LOCC demonstrated a striking increase of nearly 114% since 1990, culminating in over 208,000 deaths in 2021 alone. This dramatic rise spotlights LOCC as a growing threat in many parts of the world, particularly where healthcare infrastructure and cancer awareness remain inadequate.

Disability due to LOCC also emerged as a major challenge, with the disease accounting for over 5.8 million DALYs in 2021, reflecting years lived with illness alongside premature mortality. Critically, the burden was disproportionately higher in low and low-middle Socio-Demographic Index (SDI) countries, underlining the intersection of poverty, limited healthcare access, and higher exposure to risk factors. The regional and socio-economic disparities accentuate the compounding effect of social determinants on cancer outcomes.

The study’s analysis of risk factor attribution further elucidates the complex etiological landscape of LOCC. Smoking was identified as the single largest contributor to mortality, accounting for 23.4% of deaths. Alcohol consumption and chewing tobacco followed closely, responsible for 19.2% and 18.7% of mortality, respectively. These findings reflect the persistence of high-risk behaviors in various populations, many of which are preventable through effective public health policies and education.

Gender-specific analysis revealed disconcerting trends, with projections indicating that females will experience a sustained rise in both LOCC incidence and associated disability. This represents a critical shift in disease epidemiology that demands tailored interventions addressing the unique vulnerabilities and exposure patterns in women. The increasing female burden highlights the imperative to expand focused screening and prevention programs beyond traditional male-dominated risk assessments.

Model-based projections to 2036 offer a nuanced perspective on the evolving LOCC landscape. While mortality rates are forecasted to decline globally, the anticipated rise in incidence and DALYs, especially among women, suggests that improved survival outcomes have not yet translated into a reduction in disease occurrence or disability. This dichotomy signals advancements in treatment efficacy but also underscores persistent challenges in early detection and primary prevention.

The study’s comprehensive approach, integrating multi-dimensional data with advanced predictive modeling, sheds light on the multifaceted burden LOCC places on health systems worldwide. These insights suggest that addressing the disease’s trajectory requires a multi-pronged strategy, combining risk factor modification, early diagnosis, and equitable healthcare delivery. The disproportionate impact on lower SDI regions calls for global solidarity and investment in underserved populations to close the gap in cancer care outcomes.

Importantly, the research serves as a call to action for public health authorities and policymakers. Without concerted efforts to reduce tobacco and alcohol use and curb risky behaviors such as chewing tobacco, the projected incidence rates could overwhelm health infrastructures, especially in South Asia and similar high-risk zones. Strengthening regulation, community education, and access to cessation programs emerges as pivotal in reversing these alarming trends.

Moreover, improvements in early detection modalities can substantially alter LOCC prognosis and reduce the disability burden. Screening programs targeting high-risk groups and enhanced training for healthcare providers in recognizing early oral lesions could facilitate timely interventions, thereby mitigating progression to advanced disease stages associated with higher morbidity and mortality.

The social and economic implications of the escalating LOCC burden are profound. Beyond the human toll, increased disease prevalence strains health budgets and workforce productivity in affected regions. This underscores the importance of integrating LOCC prevention within broader non-communicable disease strategies, emphasizing sustainable health promotion and resource allocation.

As the study highlights, the interplay between behavioral risk factors and socio-economic determinants necessitates a comprehensive public health framework, tailored to the socio-cultural contexts of diverse populations. Collaborative efforts involving governments, healthcare systems, and communities are essential to design culturally sensitive interventions that effectively reduce exposure to LOCC risk factors.

In conclusion, the escalating global burden of lip and oral cavity cancer as delineated in this rigorous analysis is a clarion call to intensify global cancer control measures. The persistent high incidence, rising mortality, and substantial disability attributed to this disease underscore the urgent need for preventive policies, early detection enhancements, and addressing social inequities. By harnessing epidemiological insights and predictive analytics, the global health community can formulate evidence-based strategies to curb the LOCC epidemic and improve outcomes for vulnerable populations worldwide.

Subject of Research: Epidemiology and future projections of lip and oral cavity cancer burden globally, regionally, and nationally, with emphasis on risk factor attribution.

Article Title: Global, regional, and national burden of lip and oral cavity cancer and projections to 2036

Article References:
Meng, S., Lv, A., Li, N. et al. Global, regional, and national burden of lip and oral cavity cancer and projections to 2036. BMC Cancer 25, 1573 (2025). https://doi.org/10.1186/s12885-025-14995-z

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14995-z